EXC
50
-3
TAP
37
8
AA
69
-3
ROK
60
-2
TRIP
57
-3
NAVI
32
2
A
44
-3
JCI
52
-8
LOW
46
-16
HCA
64
-2
LMT
57
7
AMT
38
4
MU
66
11
MMM
57
-4
LLY
62
-2
NWS
44
-2
OXY
32
-5
RCL
59
-3
ZBH
45
-2
RL
76
-7
EXC
50
-3
TAP
37
8
AA
69
-3
ROK
60
-2
TRIP
57
-3
NAVI
32
2
A
44
-3
JCI
52
-8
LOW
46
-16
HCA
64
-2
LMT
57
7
AMT
38
4
MU
66
11
MMM
57
-4
LLY
62
-2
NWS
44
-2
OXY
32
-5
RCL
59
-3
ZBH
45
-2
RL
76
-7
Financhill
Back

Canaan, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Sell
39

CAN
Canaan, Inc.

Last Price:
$0.94
Seasonality Move:
75.66%
Buy
90

KYMR
Kymera Therapeutics, Inc.

Last Price:
$94.38
Seasonality Move:
7.7%
Sell
39
Canaan, Inc. (CAN) is a Sell

Is Canaan, Inc. a Buy, Sell or Hold?

  • The current Canaan, Inc. [CAN] share price is $0.94. The Score for CAN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • CAN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
90
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $94.30. The Score for KYMR is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

CAN Stock Price Chart

What is Canaan, Inc.'s stock price today?

  • The Canaan, Inc. share price today is $0.94
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CAN is experiencing selling pressure, which indicates risk of future bearish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $94.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

CAN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 43.54 Sell
Chaikin Money Flow: -10810739 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.9 - 1.14) Sell
Bollinger Bands (100): (0.66 - 1.34) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.92 Buy
Relative Strength Index (14 RSI): 86.88 Buy
Chaikin Money Flow: -462379 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.8 - 71.72) Buy
Bollinger Bands (100): (43.38 - 63.26) Buy

CAN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.96 Sell
20-day SMA: 0.97 Sell
50-day SMA: 1.24 Sell
200-day SMA: 0.91 Buy
8-day EMA: 0.95 Sell
20-day EMA: 1.01 Sell
50-day EMA: 1.06 Sell
200-day EMA: 0.64 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70 Buy
20-day SMA: 66.61 Buy
50-day SMA: 61.97 Buy
200-day SMA: 44.25 Buy
8-day EMA: 72.36 Buy
20-day EMA: 67.57 Buy
50-day EMA: 61.93 Buy
200-day EMA: 49.42 Buy

Canaan, Inc. Earnings Growth & CAN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and an increase next year of $0.17 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.

Canaan, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):